216 related articles for article (PubMed ID: 2178127)
1. Immunopathogenesis of equine infectious anemia lentivirus disease.
McGuire TC; O'Rourke KI; Perryman LE
Dev Biol Stand; 1990; 72():31-7. PubMed ID: 2178127
[TBL] [Abstract][Full Text] [Related]
2. In vitro antibody-dependent enhancement assays are insensitive indicators of in vivo vaccine enhancement of equine infectious anemia virus.
Raabe ML; Issel CJ; Montelaro RC
Virology; 1999 Jul; 259(2):416-27. PubMed ID: 10388665
[TBL] [Abstract][Full Text] [Related]
3. A particulate viral protein vaccine reduces viral load and delays progression to disease in immunized ponies challenged with equine infectious anemia virus.
Hammond SA; Cook SJ; Falo LD; Issel CJ; Montelaro RC
Virology; 1999 Feb; 254(1):37-49. PubMed ID: 9927572
[TBL] [Abstract][Full Text] [Related]
4. Control of equine infectious anemia virus is not dependent on ADCC mediating antibodies.
Tschetter JR; Byrne KM; Perryman LE; McGuire TC
Virology; 1997 Apr; 230(2):275-80. PubMed ID: 9143283
[TBL] [Abstract][Full Text] [Related]
5. An attenuated EIAV vaccine strain induces significantly different immune responses from its pathogenic parental strain although with similar in vivo replication pattern.
Lin YZ; Shen RX; Zhu ZY; Deng XL; Cao XZ; Wang XF; Ma J; Jiang CG; Zhao LP; Lv XL; Shao YM; Zhou JH
Antiviral Res; 2011 Nov; 92(2):292-304. PubMed ID: 21893100
[TBL] [Abstract][Full Text] [Related]
6. Replication ability in vitro and in vivo of equine infectious anemia virus avirulent Japanese strain.
Zheng YH; Sentsui H; Sugita M; Nakaya T; Kishi M; Hagiwara K; Inoshima Y; Ishihara C; Kono Y; Lu JL; Ikuta K
Virology; 2000 Jan; 266(1):129-39. PubMed ID: 10612667
[TBL] [Abstract][Full Text] [Related]
7. Frequency of memory cytotoxic T lymphocytes to equine infectious anemia virus proteins in blood from carrier horses.
McGuire TC; Zhang W; Hines MT; Henney PJ; Byrne KM
Virology; 1997 Nov; 238(1):85-93. PubMed ID: 9375012
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of EIAV replication and disease by immunization with a baculovirus-expressed recombinant envelope surface glycoprotein.
Wang SZ; Rushlow KE; Issel CJ; Cook RF; Cook SJ; Raabe ML; Chong YH; Costa L; Montelaro RC
Virology; 1994 Feb; 199(1):247-51. PubMed ID: 8116252
[TBL] [Abstract][Full Text] [Related]
9. Immunology of a persistent retrovirus infection--equine infectious anemia.
McGuire TC; Crawford TB
Adv Vet Sci Comp Med; 1979; 23():137-59. PubMed ID: 95154
[No Abstract] [Full Text] [Related]
10. Equine Infectious Anemia Virus (EIAV): what has HIV's country cousin got to tell us?
Leroux C; Cadoré JL; Montelaro RC
Vet Res; 2004; 35(4):485-512. PubMed ID: 15236678
[TBL] [Abstract][Full Text] [Related]
11. Natural variation of equine infectious anemia virus Gag protein cytotoxic T lymphocyte epitopes.
Zhang W; Auyong DB; Oaks JL; McGuire TC
Virology; 1999 Sep; 261(2):242-52. PubMed ID: 10497109
[TBL] [Abstract][Full Text] [Related]
12. Transient suppression of equine immune responses by equine infectious anemia virus (EIAV).
Newman MJ; Issel CJ; Truax RE; Powell MD; Horohov DW; Montelaro RC
Virology; 1991 Sep; 184(1):55-66. PubMed ID: 1651604
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of antibody parameters as potential correlates of protection or enhancement by experimental vaccines to equine infectious anemia virus.
Hammond SA; Raabe ML; Issel CJ; Montelaro RC
Virology; 1999 Sep; 262(2):416-30. PubMed ID: 10502520
[TBL] [Abstract][Full Text] [Related]
14. In vivo evolution of the gp90 gene and consistently low plasma viral load during transient immune suppression demonstrate the safety of an attenuated equine infectious anemia virus (EIAV) vaccine.
Ma J; Jiang C; Lin Y; Wang X; Zhao L; Xiang W; Shao Y; Shen R; Kong X; Zhou J
Arch Virol; 2009; 154(5):867-73. PubMed ID: 19363668
[TBL] [Abstract][Full Text] [Related]
15. Leukoencephalitis associated with selective viral replication in the brain of a pony with experimental chronic equine infectious anemia virus infection.
Oaks JL; Long MT; Baszler TV
Vet Pathol; 2004 Sep; 41(5):527-32. PubMed ID: 15347829
[TBL] [Abstract][Full Text] [Related]
16. Effects of long terminal repeat sequence variation on equine infectious anemia virus replication in vitro and in vivo.
Lichtenstein DL; Craigo JK; Leroux C; Rushlow KE; Cook RF; Cook SJ; Issel CJ; Montelaro RC
Virology; 1999 Oct; 263(2):408-17. PubMed ID: 10544113
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of viral persistence in equine infectious anemia.
Coggins L
Cornell Vet; 1975 Apr; 65(2):143-51. PubMed ID: 165036
[No Abstract] [Full Text] [Related]
18. Hyperglobulinemia and lymphocyte subset changes in naturally infected, inapparent carriers of equine infectious anemia virus.
Russell KE; Walker KM; Miller RT; Sellon DC
Am J Vet Res; 1998 Aug; 59(8):1009-15. PubMed ID: 9706205
[TBL] [Abstract][Full Text] [Related]
19. Tissue sites of persistent infection and active replication of equine infectious anemia virus during acute disease and asymptomatic infection in experimentally infected equids.
Harrold SM; Cook SJ; Cook RF; Rushlow KE; Issel CJ; Montelaro RC
J Virol; 2000 Apr; 74(7):3112-21. PubMed ID: 10708426
[TBL] [Abstract][Full Text] [Related]
20. Long terminal repeats are not the sole determinants of virulence for equine infectious anemia virus.
Tu YB; Zhou T; Yuan XF; Qiu HJ; Xue F; Sun CQ; Wang L; Wu DL; Peng JM; Kong XG; Tong GZ
Arch Virol; 2007 Jan; 152(1):209-18. PubMed ID: 16932982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
